Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.
- DOI
- 10.1007/s12282-026-01918-4
- Published
- 2026 Sep 21
- Container
- Breast cancer (Tokyo, Japan)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12282-026-01918-4,
title = {Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.},
author = {Demir N and Gökmen İ and Garbioğlu DB and Taştekin E and Işık E and Özcan E and Erdoğan B and Topaloğlu S and Köylü B and Kıkılı Cİ and Kemik F and Çiçin İ and Selçukbiricik F and Hacıoğlu MB},
year = {2026},
journal = {Breast cancer (Tokyo, Japan)},
doi = {10.1007/s12282-026-01918-4},
url = {https://doi.org/10.1007/s12282-026-01918-4}
}RIS
TY - JOUR TI - Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer. AU - Demir N AU - Gökmen İ AU - Garbioğlu DB AU - Taştekin E AU - Işık E AU - Özcan E AU - Erdoğan B AU - Topaloğlu S AU - Köylü B AU - Kıkılı Cİ AU - Kemik F AU - Çiçin İ AU - Selçukbiricik F AU - Hacıoğlu MB PY - 2026 JO - Breast cancer (Tokyo, Japan) DO - 10.1007/s12282-026-01918-4 UR - https://doi.org/10.1007/s12282-026-01918-4 ER -
APA
N, D., İ, G., DB, G., E, T., E, I., E, Ö., B, E., S, T., B, K., Cİ, K., F, K., İ, Ç., F, S., & MB, H. (2026). Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.. Breast cancer (Tokyo, Japan). https://doi.org/10.1007/s12282-026-01918-4
Source records
- pubmed · retrieved 2026-09-25T08:12:13.937Z